Remote Monitoring and Virtual Visits

Building and Developing Hybrid Monitoring SOPs for Regulatory Compliance

Posted on digi By digi

As hybrid monitoring models continue to evolve in the clinical trial ecosystem, combining both on-site and remote monitoring components, clear and actionable Standard Operating Procedures (SOPs) are essential to ensure quality, consistency, and regulatory compliance. SOPs serve as the backbone for any clinical monitoring program, guiding Clinical Research Associates (CRAs), Project Managers (PMs), and Quality Assurance (QA) professionals on how to execute hybrid strategies while meeting expectations from FDA, EMA, and ICH-GCP.
Click to read the full article.

Hybrid Monitoring Models, Remote Monitoring and Virtual Visits

Case Studies: Hybrid Monitoring in Oncology Trials – CAPA Solutions

Posted on digi By digi

Oncology clinical trials often span multiple geographies, involve complex protocols, and require extended follow-up periods. With these challenges, sponsors and CROs have increasingly adopted hybrid monitoring models—combining traditional on-site visits with remote oversight. While efficient, this model introduces new risks and responsibilities, particularly for high-stakes oncology studies.
Click to read the full article.

Hybrid Monitoring Models, Remote Monitoring and Virtual Visits

Case Study Series – Technology Enablers for Hybrid Trials

Posted on digi By digi

The evolution of hybrid clinical trial models—integrating both onsite and remote activities—has reshaped how sponsors, CROs, and investigator sites approach clinical operations. Central to this transformation is the strategic deployment of technology platforms that enable monitoring, data collection, and source verification in compliance with global regulations.
Click to read the full article.

Hybrid Monitoring Models, Remote Monitoring and Virtual Visits

Remote Escalation Handling in Hybrid Setups – Audit-Proof Guide

Posted on digi By digi

Hybrid clinical trial models introduce a new layer of complexity to monitoring and issue resolution due to the combination of onsite and remote oversight mechanisms. One of the most critical aspects of operationalizing hybrid trials is establishing a compliant, transparent, and auditable process for remote escalation handling. Whether related to protocol deviations, data discrepancies, or safety signals, escalation procedures must be clearly defined, documented, and executed in line with regulatory expectations from the FDA, EMA, and ICH GCP E6(R2)/(R3).
Click to read the full article.

Hybrid Monitoring Models, Remote Monitoring and Virtual Visits

Building Regulatory Trends Favoring Hybrid Models for Regulatory Compliance

Posted on digi By digi

The global disruption caused by the COVID-19 pandemic catalyzed a paradigm shift in clinical trial conduct, pushing regulatory bodies to embrace decentralized and hybrid models. Regulatory trends today reflect an increased acceptance of hybrid trial structures that combine traditional onsite processes with remote and digital oversight tools. Agencies like the FDA, EMA, and MHRA have published supportive guidance encouraging trial sponsors to adopt hybrid models for improved patient accessibility, data transparency, and operational flexibility—all without compromising GCP compliance.
Click to read the full article.

Hybrid Monitoring Models, Remote Monitoring and Virtual Visits

Compliance Playbook – Virtual Onboarding Programs for Sites

Posted on digi By digi

As clinical trials increasingly shift toward hybrid and decentralized models, site onboarding has also evolved. Traditional in-person site initiation visits (SIVs) are being replaced or supplemented with virtual onboarding programs. These programs are designed to educate clinical site staff on the trial protocol, regulatory requirements, data systems, and safety reporting processes—while ensuring inspection readiness and GCP compliance.
Click to read the full article.

Remote Monitoring and Virtual Visits, Remote Site Training

Case Studies on Developing eLearning Modules for Site Staff and CAPA Solutions

Posted on digi By digi

As clinical trials grow in complexity, the need for consistent, scalable, and regulatorily compliant training has led to the rise of eLearning modules for investigator site staff. Unlike traditional in-person training sessions, eLearning modules offer the flexibility of remote access and standardized content delivery. This tutorial article explores case studies of successful eLearning module development and how Corrective and Preventive Actions (CAPA) frameworks have been applied to improve their effectiveness across diverse trial settings.

Click to read the full article.

Remote Monitoring and Virtual Visits, Remote Site Training

Training Documentation in Remote Trials – Best Practices for FDA & EMA

Posted on digi By digi

As decentralized and remote clinical trials become more widespread, ensuring and documenting proper training for investigator site personnel is more critical than ever. Regulatory bodies such as the FDA, EMA, and MHRA expect sponsors to maintain comprehensive training documentation as evidence of compliance with Good Clinical Practice (GCP). This article explores best practices for documenting training in remote trial settings, highlights challenges, offers solutions based on Corrective and Preventive Actions (CAPA), and shares real-world case studies that reinforce the importance of this critical component in trial execution.

Click to read the full article.

Remote Monitoring and Virtual Visits, Remote Site Training

Assessing Competency in Online Training – Audit-Proof Guide

Posted on digi By digi

Remote training for clinical trial site personnel is now a fundamental component of decentralized and hybrid studies. However, simply delivering content through an eLearning module or webinar is not sufficient. Sponsors and CROs are increasingly being asked by regulators to prove not only that training occurred but that competency was assessed and verified. This tutorial explores best practices and tools for assessing competency in online training environments and ensuring that documentation stands up to regulatory scrutiny.

Click to read the full article.

Remote Monitoring and Virtual Visits, Remote Site Training

Hosting Global Investigator Meetings Virtually with Risk-Based Oversight Strategies

Posted on digi By digi

Global Investigator Meetings (GIMs) are pivotal in ensuring consistent trial conduct across all participating sites. Traditionally held in-person, these meetings allow sponsors to convey study objectives, review protocols, align expectations, and build rapport with investigators. However, the COVID-19 pandemic permanently shifted the paradigm towards virtual formats, introducing new challenges in training consistency, engagement, oversight, and regulatory compliance. This tutorial explores how sponsors and CROs can host effective virtual GIMs using risk-based oversight strategies that are audit-ready and CAPA-compliant.

Click to read the full article.

Remote Monitoring and Virtual Visits, Remote Site Training